Loading...
Back to narrative

506285: Interim Dividend Decision Will Drive Bullish Momentum Into Next Year

Seeds, Traits And Biofuels Will Unlock New Value Pools

506285 logo
506285
AnalystConsensusTarget
Not Invested
Published 18 May 2025

Update shared on 21 Dec 2025

Previous
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
-24.2%
7D
-0.5%

Analysts have modestly raised their price target on Bayer CropScience by about €5, citing a slightly higher long term discount rate and valuation assumptions that leave fair value largely unchanged.

What's in the News

  • Board meeting scheduled for November 7, 2025, to review unaudited financial results for the quarter ended September 30, 2025 (Key Developments)
  • Board to consider declaration of an interim dividend for the financial year 2025 to 2026 at the November 7, 2025 meeting (Key Developments)
  • Record date for the proposed interim dividend to be fixed during the upcoming board meeting (Key Developments)

Valuation Changes

  • The discount rate has risen slightly from 13.34% to 13.35%, reflecting a marginally higher required return on equity.
  • Revenue growth assumptions are essentially unchanged, remaining at 8.92% in the long-term forecast.
  • Net profit margin forecasts are stable at 12.83%, indicating an unchanged profitability outlook.
  • The future P/E multiple has increased marginally from 36.63x to 36.64x, implying almost no change in forward valuation expectations.
  • The fair value estimate remains unchanged at approximately ₹5,282 per share, suggesting that these minor parameter adjustments do not materially affect intrinsic value.

Have other thoughts on Bayer CropScience?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.